Actuals secures €3 million in Series A funding round led by Holland Capital
Amsterdam, 18th of September 2025 – Actuals, a Dutch fintech that helps finance teams process millions of transactions without errors, secures €3 million in Series A funding round led by investment firm Holland Capital.
In e-commerce, mobility, and marketplaces, millions of transactions are processed every day across dozens of different systems. Order, payment, and accounting data often do not align seamlessly. As a result, finance teams spend significant time reconciling errors, leading to manual processes, delayed closings, revenue leakage, and stress around audits.
Software platform Actuals
Actuals directly addresses this problem. Acting as an intelligent layer between existing systems, it automatically matches and validates every transaction. Deviations are flagged in real time, journal entries are automatically generated, and all transactions are captured in a complete audit trail. The result: faster book closings, reduced revenue leakage, and greater confidence for finance teams to focus on insights rather than spreadsheets. Leading e-commerce platforms and marketplaces in Europe and North America already rely on Actuals as the single source of truth for scalable and error-free financial processes.
Actuals and Holland Capital
At e-commerce and marketplace companies, the number of transactions is growing explosively. At the same time, finance teams are under pressure to accelerate automation and free up time for strategic decision-making. Regulatory requirements are also increasing: external auditors increasingly demand transaction-level detail, something outdated ERP and accounting systems cannot deliver. This creates a growing need for scalable financial infrastructure that can meet these demands.
Peter Engel, CEO and co-founder of Actuals: “We founded Actuals because we saw how finance teams were struggling with endless manual checks. Our mission is clear: to ensure that every transaction is processed correctly and transformed into reliable accounting data for companies with high transaction volumes. Working with leading brands over the past years has confirmed the urgent need to add value on top of existing ERP and accounting systems, enabling finance teams to work with confidence. The investment from Holland Capital allows us to accelerate product development and scale our international growth.”
Jorg van der Heijden, Partner at Holland Capital, says: “Holland Capital is investing in Actuals because the company solves a painful and growing problem with proven technology and deep domain expertise. Moreover, the team has a clear blueprint for international expansion. Actuals is building the financial infrastructure that modern digital companies need. With this product and a market that is ready for acceleration, we see all the ingredients for success.”
About Actuals
Actuals is a Dutch fintech that helps finance teams process millions of transactions reliably and at scale. The software platform acts as an intelligent layer between order, payment, and accounting systems, automating the matching, validation, and processing of transactions. As a result, companies benefit from faster closings, reduced revenue leakage, and complete audit trails. Leading e-commerce platforms and marketplaces in Europe and North America rely on Actuals as the single source of truth for their financial processes.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare and Technology sector.
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems Amsterdam, 21 March 2022 – We’re proud to announce that our portfolio company, CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis, has been acquired by...
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems Amsterdam, 21 March 2022 – We’re proud to announce that our portfolio company, CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis, has been acquired by...
YOEP Onderwijs & Zorg joins forces with Ad Astra
YOEP Onderwijs & Zorg joins forces with Ad Astra Amsterdam, 14th of March 2022, Our portfolio company YOEP Onderwijs en Zorg is joining forces with Ad Astra Begeleiding & Behandeling, a youth care provider which focuses on the guidance and treatment of...
YOEP Onderwijs en Zorg bundelt krachten met Ad Astra
YOEP Onderwijs en Zorg bundelt krachten met Ad Astra Amsterdam, 14 maart 2022 – Onze deelneming YOEP Onderwijs en Zorg gaat samenwerken met Ad Astra begeleiding & behandeling, een jeugdzorgaanbieder die zich richt op de begeleiding en behandeling van kinderen en...
Axual haalt groeifinanciering op bij investeerder Holland Capital
Axual haalt groeifinanciering op bij investeerder Holland Capital Utrecht/Amsterdam, 10 maart 2022 – Holland Capital investeert met een private co-investeerder in softwarebedrijf Axual, dat klanten voorziet van een platform dat real-time data streaming eenvoudiger en...
Axual raises growth financing from investor Holland Capital
Axual raises growth financing from investor Holland Capital Utrecht/Amsterdam, 10 March 2022 - Holland Capital is investing with a private co-investor in software company Axual, which provides customers with a platform that makes real-time data streaming easier and...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl